Abstract
Mesotherapy has evolved from a localized intradermal drug delivery technique into a widely utilised treatment modality in aesthetic medicine and hair restoration. Recent advances in pharmacological understanding, clinical trial methodology and treatment standardisation have strengthened the scientific foundation supporting mesotherapy. This review analyses contemporary literature, including systematic reviews, randomized controlled trials, consensus statements and clinical investigations published between 2022 and 2026. The evidence demonstrates that mesotherapy offers a minimally invasive approach capable of delivering therapeutic agents directly to target tissues while potentially reducing systemic exposure. The strongest evidence currently exists in androgenetic alopecia (AGA), where dutasteride, minoxidil, growth factors and combination therapies have demonstrated improvements in hair density, hair diameter and patient satisfaction. Emerging evidence also supports its use in facial rejuvenation and skin quality enhancement. While further large-scale randomized studies remain desirable, the current literature suggests that mesotherapy represents a valuable, safe and increasingly evidence-based treatment option within modern aesthetic medicine.
Keywords: Mesotherapy, androgenetic alopecia, hair loss, aesthetic medicine, skin rejuvenation, dutasteride, minoxidil, regenerative medicine.
Introduction
Mesotherapy was first introduced by Michel Pistor in France during the 1950s as a method of delivering therapeutic agents through superficial intradermal injections. The principle underlying mesotherapy is straightforward: administering small quantities of active compounds directly into the target tissue may improve local bioavailability while reducing systemic exposure (Tang et al., 2022). Over recent decades, mesotherapy has expanded beyond pain management and rehabilitation into dermatology, trichology and aesthetic medicine. Contemporary applications include hair restoration, skin rejuvenation, pigmentation management, cellulite treatment and facial revitalisation. Recent international consensus recommendations have further strengthened mesotherapy’s scientific credibility by establishing evidence-based guidance for its clinical application (Mammucari et al., 2026). This evolution has transformed mesotherapy from a largely empirical technique into an increasingly standardised therapeutic intervention.
Biological Rationale and Mechanisms of Action
The therapeutic rationale for mesotherapy is based upon intradermal administration of active substances into tissue layers where prolonged local activity may occur. Research suggests several mechanisms contribute to clinical outcomes. Intradermal administration creates local reservoirs of therapeutic agents, allowing prolonged exposure at the target site. Smaller total doses may be required compared with oral therapies, potentially reducing systemic adverse effects. Needle penetration itself stimulates wound-healing pathways, growth factor release, fibroblast activation and tissue remodelling. Mesotherapy may also enhance local blood flow and nutrient delivery while growth factors, vitamins, amino acids, minerals and hyaluronic acid support cellular metabolism and tissue repair. Recent proteomic investigations demonstrated that mesotherapy-related interventions modulate proteins involved in extracellular matrix organisation, energy metabolism, cellular proliferation and tissue regeneration, providing biological support for observed clinical improvements (Durand et al., 2025).
Mesotherapy in Androgenetic Alopecia
The strongest body of evidence supporting mesotherapy exists in the treatment of androgenetic alopecia. Tang et al. (2022) conducted a systematic review including 12 clinical studies involving more than 500 patients. The authors concluded that mesotherapy demonstrated positive efficacy across all included studies, with significant improvements observed in hair density, hair diameter and overall clinical appearance. Similarly, Gupta et al. (2023) reviewed 27 studies evaluating mesotherapy for hair loss and reported encouraging outcomes across multiple therapeutic agents including dutasteride, minoxidil, growth factors, botulinum toxin A, stem cell-derived therapies and multivitamin formulations. The review highlighted that mesotherapy allows therapeutic agents to remain in the scalp for longer periods while utilising lower doses than conventional systemic treatments.
Dutasteride mesotherapy has emerged as one of the most promising approaches for male and female pattern hair loss. Several studies demonstrated significant improvements in hair count, hair shaft diameter, hair density, investigator assessments and patient satisfaction. A 2025 randomized clinical trial comparing monthly and quarterly dutasteride mesotherapy found that both treatment schedules improved total hair density and achieved clinical improvement in approximately 58–64% of patients. Importantly, the treatment was generally well tolerated (Sanabria et al., 2025). Although modest systemic absorption was observed, the overall safety profile remained favourable compared with long-term oral therapy.
Evidence further suggests that combination formulations may outperform single-agent approaches. Studies combining dutasteride with biotin, dexpanthenol, pyridoxine, amino acids, peptides and growth factors have consistently demonstrated superior improvements compared with placebo and, in some cases, comparable or superior outcomes relative to topical therapies (Tang et al., 2022). These findings support the concept that mesotherapy may exert synergistic effects through multiple biological pathways.
Mesotherapy in Facial Rejuvenation and Skin Quality
Beyond hair restoration, mesotherapy has become increasingly important in facial rejuvenation. Modern mesotherapy formulations often contain hyaluronic acid, vitamins, amino acids, minerals, coenzymes and antioxidants. These compounds are intended to support fibroblast activity, collagen synthesis, hydration and extracellular matrix maintenance.
Durand et al. (2025) demonstrated that mesotherapy-inspired formulations significantly influenced pathways associated with skin metabolism, protein synthesis and extracellular matrix organisation. Clinical evaluation showed measurable improvements in skin smoothness, complexion radiance, complexion homogeneity and overall skin quality. The authors concluded that mesotherapy-based interventions contribute positively to skin rejuvenation and healthy ageing.
Safety Profile
Safety remains a critical consideration in aesthetic medicine. Across contemporary studies, reported adverse effects were generally mild and transient, including injection discomfort, mild erythema, temporary swelling, minor bruising and short-lived scalp tenderness. Serious adverse events were rare. The 2026 International Consensus Statement on Mesotherapy emphasised that adherence to standardised protocols, appropriate patient selection, aseptic technique and practitioner training substantially improves safety and clinical outcomes (Mammucari et al., 2026). Importantly, modern evidence-based mesotherapy differs considerably from earlier unregulated practices that contributed to historical controversy.
Emerging Consensus and Standardisation
One of the most significant developments in recent years has been the publication of international evidence-based recommendations for mesotherapy. Mammucari et al. (2026) reported expert consensus exceeding 92% agreement across 49 clinical recommendations. The consensus recognised mesotherapy as a legitimate intradermal therapeutic technique, a valuable option in alopecia management, a useful adjunct within personalised treatment pathways and a procedure requiring appropriate medical diagnosis and practitioner expertise. This publication represents a major milestone in the maturation of mesotherapy as an evidence-based discipline.
Limitations of Current Evidence
Although findings are encouraging, several limitations remain. Many studies involve relatively small sample sizes, treatment protocols vary considerably, outcome measures are not always standardised and long-term follow-up data remain limited. Additional large-scale randomized controlled trials would strengthen the evidence base. Nevertheless, it is notable that the overall direction of evidence is consistently positive, particularly within hair restoration and facial rejuvenation.
Clinical Implications and the Role of Kriniko Medical Aesthetics
As mesotherapy becomes increasingly evidence-based, patient outcomes depend heavily upon practitioner expertise, treatment planning and protocol selection. Kriniko Medical Aesthetics applies contemporary scientific evidence to guide treatment recommendations and ensure therapies are aligned with current best practice. Through personalised hair restoration programmes, facial rejuvenation treatments and comprehensive patient assessment, the clinic can integrate mesotherapy into bespoke treatment pathways tailored to individual patient goals. By combining rigorous safety standards, evidence-based protocols and ongoing outcome monitoring, Kriniko Medical Aesthetics aims to maximise clinical efficacy while maintaining the highest standards of patient care. As the scientific literature continues to expand, clinics that embrace research-driven practice will be best positioned to deliver predictable and clinically meaningful outcomes.
Conclusion
The contemporary literature demonstrates that mesotherapy has progressed substantially from its empirical origins. Modern evidence supports its role as a minimally invasive, targeted therapeutic intervention with particular promise in androgenetic alopecia and facial rejuvenation. Systematic reviews, randomized clinical trials and recent international consensus statements collectively indicate that mesotherapy can improve hair growth parameters, enhance skin quality and provide clinically meaningful outcomes with an acceptable safety profile. Although additional large-scale studies are warranted, the current body of evidence increasingly supports mesotherapy as a scientifically grounded and valuable component of modern aesthetic medicine. When performed by appropriately trained practitioners using evidence-based protocols, mesotherapy offers patients an effective, versatile and well-tolerated treatment option.
References
Caballero-Linares, C.F. and Rodríguez-Cuadrado, F.J. (2025) Mesotherapy with Bicalutamide: A Novel Alternative for Androgenetic Alopecia. Actas Dermo-Sifiliográficas, 116, pp. T1141–T1142.
Durand, N., Goswami, S., Henry, R., Cohen, A., Namkoong, J., Wu, J., Bourougaa, K. and Sanchez-Manoilov, L. (2025) Efficacy of a Mesotherapy-Inspired Cosmetic Serum vs. Meso-Injections: Proteomic Insights and Clinical Results. Cosmetics, 12(278), pp. 1–15.
Gupta, A.K., Ravi, S.P., Wang, T., Talukder, M., Starace, M. and Piraccini, B.M. (2023) Systematic Review of Mesotherapy: A Novel Avenue for the Treatment of Hair Loss. Journal of Dermatological Treatment, 34(1), 2245084.
Mammucari, M., Russo, D., Maggiori, E., Di Marzo, R., Rossi, M., Lugli, M. et al. (2026) Consensus Statement on Mesotherapy for Clinical and Regulatory Practice. Rheumatology International, 46, Article 39.
Sanabria, B. et al. (2025) Monthly versus Quarterly Dutasteride Mesotherapy for Male Androgenetic Alopecia: A Randomized Trial. Journal of the European Academy of Dermatology and Venereology.
Tang, Z., Hu, Y., Wang, J., Fan, Z., Qu, Q. and Miao, Y. (2022) Current Application of Mesotherapy in Pattern Hair Loss: A Systematic Review. Journal of Cosmetic Dermatology, 21(10), pp. 4184–4193.
Atiyeh, B.S., Ibrahim, A.E. and Dibo, S.A. (2008) Cosmetic Mesotherapy: Between Scientific Evidence, Science Fiction, and Lucrative Business. Aesthetic Plastic Surgery, 32(6), pp. 842–849.
Vedamurthy, M. (2007) Mesotherapy. Indian Journal of Dermatology, Venereology and Leprology, 73(1), pp. 60–62.
This format reads more like a publishable narrative review and avoids the report-style numbered sections and excessive spacing.
Discover the Benefits of Evidence-Based Mesotherapy at Kriniko Medical Aesthetics
If you are considering mesotherapy for hair restoration, facial rejuvenation, skin revitalisation or overall aesthetic enhancement, choosing an experienced medical aesthetics provider is essential. At Kriniko Medical Aesthetics, treatments are tailored to your individual concerns using evidence-based protocols, advanced techniques and a patient-centred approach.
Whether you are seeking to improve skin quality, stimulate hair growth, address early signs of ageing or explore regenerative aesthetic treatments, our team can help you develop a personalised treatment plan designed to achieve natural-looking and clinically effective results.
Book a Consultation Today
WhatsAp/text 07775809133
Landline: 01223 459 251
Address: 1010 Cambourne Business Pk, Great Cambourne, Cambourne, Cambridge CB23 6DP
Email: clinic@kriniko.co.uk
Website: https://kriniko.co.uk/